Golden Sun Health Technology Group Limited — Form 6-K Summary
Business context and reporting period
The Form 6-K, dated April 12, 2024, reports matters for the company’s extraordinary general meeting held on April 11, 2024. The filing covers April 2024 and does not provide operating or financial results.
- At the March 18, 2024 record date, the company had 19,085,491 ordinary shares outstanding: 15,055,491 Class A shares with one vote each and 4,030,000 Class B shares with five votes each.
- Shareholders representing 7,231,036 ordinary shares attended in person or by proxy, constituting a quorum.
- The shareholders approved a 10-for-1 share consolidation, effective April 18, 2024.
Financial metrics and capitalization
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics.
- Before the consolidation, authorized share capital was US$50,000, consisting of 90,000,000 Class A shares and 10,000,000 Class B shares, each with a US$0.0005 par value.
- After the consolidation, authorized share capital remains US$50,000 but will consist of 9,000,000 Class A shares and 1,000,000 Class B shares, each with a US$0.005 par value.
- Issued and outstanding shares are expected to decrease to approximately 1,908,550, comprising approximately 1,505,550 Class A shares and 403,000 Class B shares, subject to rounding adjustments.
Material changes versus the prior comparable period
- The 10-for-1 consolidation will reduce the number of issued and outstanding shares and increase the par value per share tenfold; it does not, by itself, change the company’s aggregate authorized share capital.
- Fractional shares will not be issued. Any resulting fractional share will be rounded up to the next whole share.
- The company’s Class A shares will continue trading on Nasdaq under the symbol “GSUN,” with a new CUSIP number, G4013A115, beginning on April 18, 2024.
Guidance, outlook, risks, contingencies, and unusual items
- The consolidation was proposed to help the company regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price, and to mitigate the risk of delisting.
- The company stated that it had until May 16, 2024 to regain compliance.
- Shares held electronically through brokerage accounts will be adjusted automatically; holders generally do not need to take action.
- The filing provides no revenue guidance, earnings outlook, or management forecast.
Shareholder vote
The resolution was approved with 23,195,724 votes for, 154,362 against, and 950 abstentions. The filing text also displays an isolated “1” in the vote presentation without clearly identifying its meaning.
Important facts for investors to verify
- Confirm that the 10-for-1 consolidation became effective at the opening of Nasdaq trading on April 18, 2024.
- Verify the post-consolidation share count, including any additional shares created through fractional-share rounding.
- Confirm whether the company regained compliance with Nasdaq’s minimum bid-price requirement by the May 16, 2024 deadline.
- Verify the new CUSIP, G4013A115, and the continued use of the GSUN trading symbol.
- Review subsequent SEC filings for any delisting notice, financing, dilution, or changes in capitalization.